Trial · NCT01536795
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Safety: Overview of Adverse Events | WR279,396 With Tegaderm Dressing | Subjects with atleast 1 AE | 16 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Gauze and Tape Dressing | Subjects with atleast 1 AE | 7 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Tegaderm Dressing | Subjects with an SAE | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Gauze and Tape Dressing | Subjects with an SAE | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Tegaderm Dressing | Withdrawals due to an AE | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Gauze and Tape Dressing | Withdrawals due to an AE | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Tegaderm Dressing | Not due to an AE | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Gauze and Tape Dressing | Not due to an AE | 1 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Tegaderm Dressing | Deaths | 0 | Participants | |
| Safety: Overview of Adverse Events | WR279,396 With Gauze and Tape Dressing | Deaths | 0 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Tegaderm Dressing | Day 50 - Not Evaluable | 1 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Gauze and Tape Dressing | Day 50 - Not Evaluable | 2 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Tegaderm Dressing | Day 50 - Cured | 19 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Gauze and Tape Dressing | Day 50 - Cured | 20 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Tegaderm Dressing | Day 50 - Improved | 2 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Gauze and Tape Dressing | Day 50 - Improved | 2 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Tegaderm Dressing | Day 50 - Failure | 2 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Gauze and Tape Dressing | Day 50 - Failure | 0 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Tegaderm Dressing | Day 90 - Not Evaluable | 1 | Participants | |
| Clinical Responses of Index Lesions (100% Re-epithelialization) | WR279,396 With Gauze and Tape Dressing | Day 90 - Not Evaluable | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01536795/results